Global Liposomes Drug Delivery Market Research Report 2023(Status and Outlook)

Global Liposomes Drug Delivery Market Research Report 2023(Status and Outlook)



Report Overview

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

The Global Liposomes Drug Delivery Market Size was estimated at USD 3087.70 million in 2022 and is projected to reach USD 6017.05 million by 2029, exhibiting a CAGR of 10.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Liposomes Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Liposomes Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Liposomes Drug Delivery market in any manner.

Global Liposomes Drug Delivery Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Johnson & Johnson

Gilead Sciences

Pacira

Sun Pharmaceutical

Luye Pharma

Sigma-Tau Group

Fudan-Zhangjiang

Teva Pharmaceutical

CSPC

Novartis

Kingond Pharm

Spectrum Pharmaceuticals

Shanghai New Asia

Market Segmentation (by Type)

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Market Segmentation (by Application)

City Bicycle

Road Bicycle

Mountain Bicycle

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Liposomes Drug Delivery Market

Overview of the regional outlook of the Liposomes Drug Delivery Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liposomes Drug Delivery
1.2 Key Market Segments
1.2.1 Liposomes Drug Delivery Segment by Type
1.2.2 Liposomes Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liposomes Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Liposomes Drug Delivery Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Liposomes Drug Delivery Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liposomes Drug Delivery Market Competitive Landscape
3.1 Global Liposomes Drug Delivery Sales by Manufacturers (2018-2023)
3.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2018-2023)
3.3 Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liposomes Drug Delivery Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Liposomes Drug Delivery Sales Sites, Area Served, Product Type
3.6 Liposomes Drug Delivery Market Competitive Situation and Trends
3.6.1 Liposomes Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liposomes Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liposomes Drug Delivery Industry Chain Analysis
4.1 Liposomes Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liposomes Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liposomes Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liposomes Drug Delivery Sales Market Share by Type (2018-2023)
6.3 Global Liposomes Drug Delivery Market Size Market Share by Type (2018-2023)
6.4 Global Liposomes Drug Delivery Price by Type (2018-2023)
7 Liposomes Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liposomes Drug Delivery Market Sales by Application (2018-2023)
7.3 Global Liposomes Drug Delivery Market Size (M USD) by Application (2018-2023)
7.4 Global Liposomes Drug Delivery Sales Growth Rate by Application (2018-2023)
8 Liposomes Drug Delivery Market Segmentation by Region
8.1 Global Liposomes Drug Delivery Sales by Region
8.1.1 Global Liposomes Drug Delivery Sales by Region
8.1.2 Global Liposomes Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Liposomes Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liposomes Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liposomes Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liposomes Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liposomes Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Johnson andamp; Johnson
9.1.1 Johnson andamp; Johnson Liposomes Drug Delivery Basic Information
9.1.2 Johnson andamp; Johnson Liposomes Drug Delivery Product Overview
9.1.3 Johnson andamp; Johnson Liposomes Drug Delivery Product Market Performance
9.1.4 Johnson andamp; Johnson Business Overview
9.1.5 Johnson andamp; Johnson Liposomes Drug Delivery SWOT Analysis
9.1.6 Johnson andamp; Johnson Recent Developments
9.2 Gilead Sciences
9.2.1 Gilead Sciences Liposomes Drug Delivery Basic Information
9.2.2 Gilead Sciences Liposomes Drug Delivery Product Overview
9.2.3 Gilead Sciences Liposomes Drug Delivery Product Market Performance
9.2.4 Gilead Sciences Business Overview
9.2.5 Gilead Sciences Liposomes Drug Delivery SWOT Analysis
9.2.6 Gilead Sciences Recent Developments
9.3 Pacira
9.3.1 Pacira Liposomes Drug Delivery Basic Information
9.3.2 Pacira Liposomes Drug Delivery Product Overview
9.3.3 Pacira Liposomes Drug Delivery Product Market Performance
9.3.4 Pacira Business Overview
9.3.5 Pacira Liposomes Drug Delivery SWOT Analysis
9.3.6 Pacira Recent Developments
9.4 Sun Pharmaceutical
9.4.1 Sun Pharmaceutical Liposomes Drug Delivery Basic Information
9.4.2 Sun Pharmaceutical Liposomes Drug Delivery Product Overview
9.4.3 Sun Pharmaceutical Liposomes Drug Delivery Product Market Performance
9.4.4 Sun Pharmaceutical Business Overview
9.4.5 Sun Pharmaceutical Liposomes Drug Delivery SWOT Analysis
9.4.6 Sun Pharmaceutical Recent Developments
9.5 Luye Pharma
9.5.1 Luye Pharma Liposomes Drug Delivery Basic Information
9.5.2 Luye Pharma Liposomes Drug Delivery Product Overview
9.5.3 Luye Pharma Liposomes Drug Delivery Product Market Performance
9.5.4 Luye Pharma Business Overview
9.5.5 Luye Pharma Liposomes Drug Delivery SWOT Analysis
9.5.6 Luye Pharma Recent Developments
9.6 Sigma-Tau Group
9.6.1 Sigma-Tau Group Liposomes Drug Delivery Basic Information
9.6.2 Sigma-Tau Group Liposomes Drug Delivery Product Overview
9.6.3 Sigma-Tau Group Liposomes Drug Delivery Product Market Performance
9.6.4 Sigma-Tau Group Business Overview
9.6.5 Sigma-Tau Group Recent Developments
9.7 Fudan-Zhangjiang
9.7.1 Fudan-Zhangjiang Liposomes Drug Delivery Basic Information
9.7.2 Fudan-Zhangjiang Liposomes Drug Delivery Product Overview
9.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Product Market Performance
9.7.4 Fudan-Zhangjiang Business Overview
9.7.5 Fudan-Zhangjiang Recent Developments
9.8 Teva Pharmaceutical
9.8.1 Teva Pharmaceutical Liposomes Drug Delivery Basic Information
9.8.2 Teva Pharmaceutical Liposomes Drug Delivery Product Overview
9.8.3 Teva Pharmaceutical Liposomes Drug Delivery Product Market Performance
9.8.4 Teva Pharmaceutical Business Overview
9.8.5 Teva Pharmaceutical Recent Developments
9.9 CSPC
9.9.1 CSPC Liposomes Drug Delivery Basic Information
9.9.2 CSPC Liposomes Drug Delivery Product Overview
9.9.3 CSPC Liposomes Drug Delivery Product Market Performance
9.9.4 CSPC Business Overview
9.9.5 CSPC Recent Developments
9.10 Novartis
9.10.1 Novartis Liposomes Drug Delivery Basic Information
9.10.2 Novartis Liposomes Drug Delivery Product Overview
9.10.3 Novartis Liposomes Drug Delivery Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Kingond Pharm
9.11.1 Kingond Pharm Liposomes Drug Delivery Basic Information
9.11.2 Kingond Pharm Liposomes Drug Delivery Product Overview
9.11.3 Kingond Pharm Liposomes Drug Delivery Product Market Performance
9.11.4 Kingond Pharm Business Overview
9.11.5 Kingond Pharm Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Liposomes Drug Delivery Basic Information
9.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Overview
9.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Shanghai New Asia
9.13.1 Shanghai New Asia Liposomes Drug Delivery Basic Information
9.13.2 Shanghai New Asia Liposomes Drug Delivery Product Overview
9.13.3 Shanghai New Asia Liposomes Drug Delivery Product Market Performance
9.13.4 Shanghai New Asia Business Overview
9.13.5 Shanghai New Asia Recent Developments
10 Liposomes Drug Delivery Market Forecast by Region
10.1 Global Liposomes Drug Delivery Market Size Forecast
10.2 Global Liposomes Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liposomes Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Liposomes Drug Delivery Market Size Forecast by Region
10.2.4 South America Liposomes Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liposomes Drug Delivery by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Liposomes Drug Delivery Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Liposomes Drug Delivery by Type (2024-2029)
11.1.2 Global Liposomes Drug Delivery Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Liposomes Drug Delivery by Type (2024-2029)
11.2 Global Liposomes Drug Delivery Market Forecast by Application (2024-2029)
11.2.1 Global Liposomes Drug Delivery Sales (K MT) Forecast by Application
11.2.2 Global Liposomes Drug Delivery Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings